ARECOR THERAPEUTICS PLC
Biopharmaceutical company enhancing medicines with its proprietary formulation technology.
AREC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMWLM973
- LEI:
- 98450093D12I3A8DDD58
- Country:
- United Kingdom
- Address:
- Chesterford Research Park, CB10 1XL Saffron Walden
- Website:
- https://arecor.com/
- Sector:
- Manufacturing
Description
Arecor Therapeutics plc is a clinical-stage biopharmaceutical company focused on developing enhanced therapeutic medicines. The company utilizes its proprietary Arestat® technology platform, a formulation science designed to improve the properties of proteins and peptides, enabling superior drug product profiles. Arecor's business model involves two approaches: developing an internal portfolio of proprietary products and partnering with pharmaceutical and medtech companies to enhance their therapeutic offerings. The company's in-house development pipeline is primarily focused on advancing treatments for diabetes and other cardiometabolic diseases, including next-generation insulin candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-08 15:48 |
Result of General Meeting and Total Voting Rights
|
English | 27.3 KB | ||
| 2024-07-23 17:26 |
Posting of Circular and General Meeting
|
English | 19.6 KB | ||
| 2024-07-23 08:00 |
Result of WRAP Retail Offer
|
English | 49.2 KB | ||
| 2024-07-19 19:22 |
Result of Placing and Subscription
|
English | 60.5 KB | ||
| 2024-07-19 14:17 |
WRAP Retail Offer to raise up to £1 million
|
English | 35.3 KB | ||
| 2024-07-19 14:10 |
Proposed Placing and Subscription
|
English | 206.2 KB | ||
| 2024-06-28 15:35 |
Result of AGM
|
English | 13.1 KB | ||
| 2024-06-10 08:00 |
Trading and Funding Update
|
English | 14.5 KB | ||
| 2024-05-31 17:05 |
Posting of 2023 Annual Report and Notice of AGM
|
English | 13.7 KB | ||
| 2024-05-23 08:00 |
Grant of Options and PDMR Dealing
|
English | 56.8 KB | ||
| 2024-05-21 08:00 |
Arecor to host company and KOL webinar today
|
English | 17.6 KB | ||
| 2024-05-20 08:00 |
Positive headline results for AT278 clinical trial
|
English | 24.1 KB | ||
| 2024-05-16 08:00 |
Final results for 2023
|
English | 621.2 KB | ||
| 2024-05-14 11:17 |
Notice of Results
|
English | 13.1 KB | ||
| 2024-05-09 08:00 |
Arecor and Medtronic Diabetes collaboration
|
English | 17.8 KB |
Automate Your Workflow. Get a real-time feed of all ARECOR THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ARECOR THERAPEUTICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ARECOR THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
